Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia

Paolo Strati; Michael J. Keating; Jan A. Burger; Susan M. O’Brien; William G. Wierda; Zeev Estrov; Gracy Zacharian; Alessandra Ferrajoli

doi:10.3324/haematol.2017.171561

Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia

Paolo Strati, Michael J. Keating, Jan A. Burger, Susan M. O’Brien, William G. Wierda, Zeev Estrov, Gracy Zacharian, Alessandra Ferrajoli

Research output: Contribution to journal › Letter › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	e494-e496
Journal	Haematologica
Volume	102
Issue number	12
DOIs	https://doi.org/10.3324/haematol.2017.171561
State	Published - Nov 30 2017

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2017.171561

Cite this

@article{7667dfc4bf7b4368858453c4664724c1,

title = "Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia",

author = "Paolo Strati and Keating, {Michael J.} and Burger, {Jan A.} and O{\textquoteright}Brien, {Susan M.} and Wierda, {William G.} and Zeev Estrov and Gracy Zacharian and Alessandra Ferrajoli",

note = "Funding Information: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Funding: the University of Texas MD Anderson Cancer Center is supported in part by the National Institutes of Health through Cancer Center Support Grant P30CA016672. Correspondence: aferrajo@mdanderson.org doi:10.3324/haematol.2017.171561 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",

year = "2017",

month = nov,

day = "30",

doi = "10.3324/haematol.2017.171561",

language = "English (US)",

volume = "102",

pages = "e494--e496",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "12",

}

TY - JOUR

T1 - Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia

AU - Strati, Paolo

AU - Keating, Michael J.

AU - Burger, Jan A.

AU - O’Brien, Susan M.

AU - Wierda, William G.

AU - Estrov, Zeev

AU - Zacharian, Gracy

AU - Ferrajoli, Alessandra

N1 - Funding Information: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Funding: the University of Texas MD Anderson Cancer Center is supported in part by the National Institutes of Health through Cancer Center Support Grant P30CA016672. Correspondence: aferrajo@mdanderson.org doi:10.3324/haematol.2017.171561 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2017/11/30

Y1 - 2017/11/30

UR - http://www.scopus.com/inward/record.url?scp=85037028455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037028455&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.171561

DO - 10.3324/haematol.2017.171561

M3 - Letter

C2 - 28798068

AN - SCOPUS:85037028455

SN - 0390-6078

VL - 102

SP - e494-e496

JO - Haematologica

JF - Haematologica

IS - 12

ER -

Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this